Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.

2.

Prior authorizations draining time, energy from many cancer patients

3.

FDA Expands Approval of Osimertinib in Lung Cancer

4.

Increased detection of adenomas may reduce colon cancer risk after colonoscopy in FIT-based screening.

5.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot